MetLife Originates $9.6B+ in Commercial Mortgages, Invests $1.7B in Real Estate Equity in 2012

Loading...
Loading...
MetLife, Inc.
MET
announced today that it originated, through its real estate investments department, over $9.6 billion in commercial mortgage loans in 2012. MetLife continues to be the largest portfolio lender in the insurance industry with $43.1 billion in commercial mortgages outstanding at year end 2012. MetLife participated in a number of high-quality commercial mortgage transactions with loan sizes of $175 million and above during 2012. Some noteworthy transactions included: * $362 million loan on Waterside Plaza, a 1,471-unit apartment complex built over the East River in Manhattan; * $264 million loan on Broadgate West, a Class A, top quality office complex in London; * $258 million loan on The Westin in Times Square, a hotel located in Manhattan; * $253 million loan on 101 California, a Class A, top quality office tower located in San Francisco; * $200 million loan on a portfolio of retail properties in the U.K.; and * $183 million loan collateralized by a portfolio of 39 industrial properties diversified in 10 Mexican markets. Within its international portfolio, MetLife successfully grew its commercial mortgage lending activities in 2012, originating over $1 billion in the U.K., $191 million in Mexico and more than 33.6 billion yen for its Japanese local account. In October 2012, MetLife reorganized its real estate arm to better manage its investments and the investments for its institutional investors and launched a third party asset management business within the real estate investments department. This enables the company to use its extensive experience in real estate to create investment opportunities that generate attractive, long-term returns for institutional investors.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...